Introduction Naltrexone is a pure opioid antagonist primarily used to prevent relapse in opioid use disorder and reduce alcohol craving in alcohol dependence. It competitively blocks μ-opioid receptors and to a lesser extent κ and δ receptors, thereby diminishing the rewarding effects of opioids and alcohol without inducing any agonist activity. Step-by-Step Mechanism of Action … Read more
Introduction Mirabegron is a β₃‑adrenergic receptor agonist used to treat overactive bladder (OAB). By selectively activating β₃‑receptors in the detrusor muscle of the bladder, it enhances urine storage and reduces urinary urgency and frequency without significantly affecting cardiovascular β₁ or β₂ receptors. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value Bioavailability ~29% (fasting) Peak Plasma … Read more
Introduction Aripiprazole is a third-generation atypical antipsychotic approved for treating schizophrenia, bipolar disorder, depression (as an adjunct), Tourette’s syndrome, and irritability in autism. It is pharmacologically unique for its role as a partial agonist at dopamine D₂ and serotonin 5‑HT₁A receptors, and as an antagonist at serotonin 5‑HT₂A receptors, allowing it to modulate neurotransmission rather … Read more
Introduction Ticagrelor is an oral antiplatelet agent used in the management of acute coronary syndrome (ACS) and for secondary prevention of thrombotic events. It directly and reversibly inhibits the P2Y₁₂ receptor on platelets, thereby preventing ADP-induced platelet aggregation. Unlike thienopyridines like clopidogrel, it does not require metabolic activation, leading to a faster and more predictable … Read more
Introduction Vyvanse (lisdexamfetamine) is a central nervous system stimulant used to treat ADHD and binge-eating disorder. It is a prodrug, meaning it becomes active only after enzymatic conversion in the body. This mechanism provides a smoother onset, extended action, and lower risk of misuse. Its active metabolite, dextroamphetamine, boosts dopamine and norepinephrine in the brain—improving … Read more
Introduction Dexmedetomidine is a highly selective alpha-2 adrenergic receptor agonist used for sedation in intensive care settings and during surgical procedures. It provides sedation without significant respiratory depression, distinguishing it from other sedatives like benzodiazepines and propofol. Its analgesic-sparing and sympatholytic effects further enhance its clinical utility. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value … Read more
Introduction Apixaban is a direct oral anticoagulant (DOAC) used to prevent and treat thrombosis. It is specifically indicated for stroke prevention in non-valvular atrial fibrillation, treatment and prevention of venous thromboembolism (VTE), and management of deep vein thrombosis (DVT) and pulmonary embolism (PE). Its predictable pharmacokinetics and oral administration make it a widely used alternative … Read more
Introduction Empagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by promoting urinary glucose excretion. It also provides cardiovascular and renal protective benefits, and is approved for type 2 diabetes mellitus, heart failure, and chronic kidney disease. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value Route Oral, taken once daily Bioavailability ~78% … Read more
Introduction GLP-1 receptor agonists are a class of antidiabetic drugs that mimic the action of glucagon-like peptide-1 (GLP-1), an incretin hormone that enhances insulin secretion in response to meals. These agents are used primarily in the treatment of type 2 diabetes mellitus and obesity. Their unique ability to improve glycemic control without causing significant hypoglycemia, … Read more
Introduction Carbidopa–Levodopa is a cornerstone therapy in the management of Parkinson’s disease. Levodopa serves as a precursor to dopamine, replenishing depleted levels in the brain, while carbidopa prevents premature peripheral metabolism of levodopa, ensuring its availability in the central nervous system. Together, they effectively improve motor symptoms such as bradykinesia, rigidity, and tremor. Step-by-Step Mechanism … Read more
